COVID-19

PM announces changes to COVID-19 vaccine strategy

This morning Prime Minister Scott Morrison gave a press conference to deliver an update on Australia’s COVID-19 vaccine strategy.

This morning Prime Minister Scott Morrison gave a press conference to deliver an update on Australia’s COVID-19 vaccine strategy.

Morrison said “our vaccine strategy and policy had identified 4 possible vaccines for Australians, however at no stage did we believe that all 4 vaccines would have gotten through the process, which is why we spread out risk and pre-prepared to deal with any issues along the way.”

He went on to say that the National Security Committee met this week and discussed the vaccine strategy, and it was decided that the University of QLD vaccine won’t proceed and will no longer feature as part of Australia’s vaccine plan.

A risk of false positive HIV results were possible, which comes from the protein used, so the risk to vaccine confidence was the primary factor here.

Morrison said that as part of Australia’s strategy, we are now increasing the order for Astrazeneca vaccine, which will be manufactured here in Melbourne, to 53.8 million, enough to cover our entire population, and increasing the Novavax vaccine doses from 40 million to 51 million, which will also be enough doses enough to cover our entire population.

This is the highest proportion of vaccines to population in any country in the world.

The Health Minister Greg Hunt said “We are now seeing 600,000 a cases a day around the world, and Australia by comparison have a fortunate situation driven by following the science and scientific advice and planning, planning, planning. We will be strengthened our situation in relation to two vaccines, and discontinuing our work with the University of Queensland vaccine. As a result, there is the potential for slightly earlier completion as a result of focusing our attention on three, rather than four vaccines.”

Related News

[adrotate banner="159"]
To Top